Thousands of Patients from Scotland’s Poorest Areas to Benefit from Landmark UK Taxpayer-Funded Obesity Study
Scottish patients placed at the heart of a multi-million pound study of weight-loss medicines Thousands of Patients from Scotland’s Poorest Areas to Benefit from Landmark UK Taxpayer-Funded Obesity Study Scottish patients placed at the heart of a multi-million pound study of weight-loss medicines. University of Glasgow, pharmaceutical firm Novo Nordisk and IQVIA, a leading global provider of clinical research services, selected to plan and deliver the research involving 3,000 to 5,000 people...